Ligand validation:5HXR

MYS: PENTADECANE

MYS is a Ligand Of Interest in 5HXR designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
5HXR_MYS_A_405	12%	69%	0.158	0.814	0.44	0.73	-	-	0	0	27%	0.2667
5HXR_MYS_A_407	10%	72%	0.16	0.746	0.35	0.72	-	-	1	0	53%	0.5333
5HXR_MYS_A_410	8%	71%	0.279	0.835	0.33	0.77	-	-	1	0	53%	0.5333
5HXR_MYS_A_409	5%	67%	0.294	0.711	0.33	0.92	-	-	1	0	100%	1
5HXR_MYS_A_413	5%	67%	0.256	0.686	0.34	0.9	-	-	0	0	87%	0.8667
5HXR_MYS_A_406	2%	78%	0.4	0.833	0.36	0.54	-	-	0	0	33%	0.3333
5HXR_MYS_A_411	2%	69%	0.376	0.711	0.44	0.76	-	-	1	0	87%	0.8667
5HXR_MYS_A_412	2%	72%	0.432	0.793	0.35	0.71	-	-	1	0	60%	0.6
5HXR_MYS_A_408	1%	70%	0.565	0.696	0.34	0.8	-	-	0	0	73%	0.7333
3V5U_MYS_A_714	31%	66%	0.156	0.858	0.41	0.88	-	-	1	0	80%	0.8
5JDG_MYS_A_423	26%	69%	0.154	0.927	0.44	0.73	-	-	0	0	27%	0.2667
5HXE_MYS_A_410	24%	69%	0.183	0.81	0.37	0.83	-	-	0	0	100%	1
5HWY_MYS_A_414	23%	69%	0.157	0.911	0.43	0.74	-	-	0	0	27%	0.2667
5JDH_MYS_A_415	22%	69%	0.156	0.9	0.44	0.73	-	-	0	0	27%	0.2667
6LPK_MYS_A_2409	55%	84%	0.13	0.896	0.25	0.5	-	-	0	0	100%	1
6LPJ_MYS_A_2426	53%	78%	0.13	0.89	0.2	0.68	-	-	0	0	100%	1
4QND_MYS_A_101	44%	93%	0.13	0.868	0.08	0.41	-	-	1	0	93%	0.9333
5H2K_MYS_A_606	25%	72%	0.185	0.822	0.3	0.78	-	-	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.